Viper ULTRA 溶栓導管

Viper ULTRA 溶栓導管

顏色 ultra infusion catheter specialized for direct thrombolytic delivery, featuring multi-hole design to uniformly distribute drugs across large clot segments.

資訊

的 Viper® Ultrasonic Pharmacomechanical Thrombolysis System 是一個 微創 device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin 和 increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications 和 preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

產品規格

規格 細節 / 價值
產品名稱 Viper ULTRA 溶栓導管
預期用途 在急性或亞急性血栓（周邊、靜脈或動脈）中導管導向輸注溶栓劑
導管設計 多孔遠端區段可均勻分散藥物，頂端可能有不透射標記
材質 Pebax/Polyamide 軸心，可能編織或強化
外徑 (F) ~4-6F (視輸液腔容量而定)
工作長度 ~80-150 公分（依產品編號而異）
輸液口 在定義的區段上分佈側邊連接埠，提供一致的溶栓輸送
導線相容性 通常為 0.014 吋或 0.018 吋
無菌 無菌，單次使用
保質期 ~2-3 年，如果在 15-25 °C 密封包裝下儲存
臨床適應症 針對深層靜脈血栓、周邊動脈閉塞輸注溶栓劑，可能用於移植物內血栓形成
禁忌症 高度鈣化的病變、嚴重血管迂曲導致無法安全通過、已知裝置材料過敏

訂購與尺寸表

外徑 (F) 工作長度（公分） 輸液區段 (cm) 產品編號 注意事項
4F 80 10 VPR-4F-80-10 較小的外徑適合遠端或小血管使用
4F 120 15 VPR-4F-120-15 較長的軸心、適中的灌注段
5F 80 10 VPR-5F-80-10 外徑稍大，可承受較重的凝塊負荷
5F 120 20 VPR-5F-120-20 加長的長度與更長的輸液區域
6F 100 15 VPR-6F-100-15 多層次周邊病變的常見尺寸
6F 150 30 VPR-6F-150-30 最大長度，廣泛輸液區段

相關商品